Archives for September 26, 2011

← 2011

Unigene cuts SDBG to focus gaze on peptides

By Natalie Morrison

Peptide-based therapeutics specialists Unigene will focus on high valuation drug development and drug delivery opportunities after cutting loose its Site Directed Bone Growth (SDBG) patent portfolio.